Voio Inc.

Voio Inc. , based in the US, provides advanced radiology solutions designed to enhance diagnostic efficiency through AI-driven technology, empowering healthcare professionals to generate rapid and accurate reports. Voio Inc. specializes in providing innovative radiology solutions that streamline diagnostic processes.

Founded in 2025 in Berkeley, US, the company secured USD 8. 6 mn in Seed funding co-led by Laude Ventures and The House Fund on November 20, 2025. It has completed a total of 1 deal to date. Voio specializes in advanced radiology solutions designed to streamline the diagnostic process for healthcare professionals.

The company's core offerings include AI-driven clinical models that enhance the capabilities of radiologists by providing smart autocompletes derived from image analysis, enabling draft reports to be generated in seconds. This technology empowers generalist radiologists to perform at a specialist's level, improving the detection of subtle findings across a variety of conditions. Voio's solutions aim to transform radiology from a reactive to a proactive practice, identifying diseases before they manifest. The company's products have been implemented in over 90 hospitals across 30 countries, catering to a diverse clientele that includes healthcare providers and institutions focused on enhancing diagnostic accuracy and efficiency in patient care.

Voio generates revenue through strategic partnerships and B2B transactions, positioning its services directly within healthcare organizations. The company offers a subscription-based model, allowing clients such as hospitals and diagnostic centers to access its suite of AI tools for ongoing use and integration into their reporting systems. By providing clinical models that support various radiology tasks, Voio ensures that its clients can facilitate faster and more accurate diagnoses. The pricing structure is designed to accommodate healthcare providers of different sizes, reflecting the value of its advanced technology in improving clinical outcomes.

This approach enhances operational efficiency for its clients and positions Voio as a critical player in the evolving landscape of medical AI solutions. Following its recent funding of USD 8. 6 mn in Seed financing on November 20, 2025, Voio plans to expand its AI platform for radiology and further develop its Pillar‑0 imaging model. The company aims to launch new products that will enhance its service offerings and is focused on expanding into new geographic markets to increase its global footprint.